Close Menu
Home » QuanDx to Distribute Zeesan's High-Risk HPV Genotyping Assay in Europe

QuanDx to Distribute Zeesan's High-Risk HPV Genotyping Assay in Europe

Nov 25, 2015
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – QuanDx, a San Francisco-based biotechnology firm focused on personalized cancer diagnostics, has announced a worldwide distribution agreement with Zeesan Biotech for that firm's MeltPro High Risk HPV Genotyping Assay. The deal excludes China, and terms of the agreement were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Hahn Hearing

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

RNAi Drug for Acute Hepatic Porphyria

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Decade of DTC

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

Nature Studies Examine Native RNA Sequencing, Nanopore Sequencing Approach to Analyze STR Expansions

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

What's Popular?

In PCR

  1. Private Equity Firms Cinven, Astorg to Acquire LGC

  2. T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel

  3. Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

  4. Genedrive Receives CE Mark for Hearing Loss Assay

  5. Paragon Genomics Discusses New Gene Fusion Detection Method, Cystic Fibrosis Panel

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.